Pharmacological Studies in Hospitalized COVID-19 Patients in Belgium: We Could Do Better

Belgium has actively participated in clinical research on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) since the beginning of the pandemic to help identify effective and safe treatments for COVID-19. The objective of this review is to provide a picture of the clinical studies carried out in hospitalized patients with COVID-19 in Belgium. We collected data on all randomized, interventional trials in patients with COVID-19 that were registered on two recognized clinical trial registers, started enrollment before 31 December 2021, and included at least one patient in a Belgian cen... Mehr ...

Verfasser: Maya Hites
Jean-Louis Vincent
Dokumenttyp: Artikel
Erscheinungsdatum: 2022
Reihe/Periodikum: Viruses, Vol 14, Iss 1427, p 1427 (2022)
Verlag/Hrsg.: MDPI AG
Schlagwörter: Belgium / adaptive platform trials / severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) / Microbiology / QR1-502
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-26613774
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/v14071427